Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat
Growth hormone (GH) has neuroprotective effects that have not been evaluated in the mammalian visual system. This study tested the hypothesis that GH administration can promote retinal neuroprotection in an optic nerve crush (ONC) model in male rats. The ON was compressed for 10 seconds, and bovine...
Gespeichert in:
Veröffentlicht in: | Investigative ophthalmology & visual science 2024-11, Vol.65 (13), p.17 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 13 |
container_start_page | 17 |
container_title | Investigative ophthalmology & visual science |
container_volume | 65 |
creator | Epardo, David Balderas-Márquez, Jerusa E Rodríguez-Arzate, Cynthia A Thébault, Stéphanie C Carranza, Martha Luna, Maricela Ávila-Mendoza, José Calderón-Vallejo, Denisse Quintanar, J Luis Arámburo, Carlos Martínez-Moreno, Carlos G |
description | Growth hormone (GH) has neuroprotective effects that have not been evaluated in the mammalian visual system. This study tested the hypothesis that GH administration can promote retinal neuroprotection in an optic nerve crush (ONC) model in male rats.
The ON was compressed for 10 seconds, and bovine GH was injected concomitantly to injury for 14 days (0.5 µg/g every 12 hours). At 24 hours and 14 days after ONC, we evaluated the effects of GH upon several markers by quantitative PCR (qPCR), Western blot, and immunohistochemistry; the ON integrity was assessed using CTB Alexa 488 anterograde tracer, and retinal function was tested by full-field electroretinogram.
GH partially prevented the ONC-induced death of retinal ganglion cells (RGCs), as well as the increase in gliosis marker GFAP at 14 days. Most of the ONC-induced changes in mRNA retinal levels of several neurotrophic, survival, synaptogenic, gliosis, and excitotoxicity markers were prevented by GH, both at 24 hours and 14 days, and treatment also stimulated the expression of antiapoptotic proteins Bcl-2 and Bcl-xL at 24 hours. Additionally, GH partially maintained the ON integrity and active anterograde transport, as well as retinal function by avoiding the reduced amplitude and slowing of the A- and B-waves and oscillatory potentials associated with the ONC at 14 days.
GH has neuroprotective effects in the ONC model in male rats, it promoted RGC survival, gliosis reduction, and axonal transport increase, likely through the regulation of genes involved in neuroprotection, survival, and synaptogenesis. Furthermore, GH prevented functional impairment, indicating its potential as a therapeutic option for retinal neurodegenerative diseases. |
doi_str_mv | 10.1167/iovs.65.13.17 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11549927</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3124690935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c235t-a94f52d4258e99a87c409919c9fc5739a2c62e9c9382110ca2906457a84e29863</originalsourceid><addsrcrecordid>eNpVUU1PAjEUbIxGED16NT162bWfu9uTIQTBRCUaPTe1vJU1yxbbLsZ_7xKQ4OnNy0zmTd4gdElJSmmW31RuHdJMppSnND9CfSolS2Re8OMD3ENnIXwSwihl5BT1uJJEEFH00fPEu--4wFPnl64B_AStdyvvIthYrQGPy7JDAQ_LCB6bBs9WsbKdzHfkyLdhgasGxwXgR1MDfjHxHJ2Upg5wsZsD9HY3fh1Nk4fZ5H40fEgs4zImRolSsrlgsgClTJFbQZSiyqrSypwrw2zGoFt50aUm1jBFMiFzUwhgqsj4AN1ufVft-xLmFproTa1Xvloa_6OdqfR_pqkW-sOtNaVSKMXyzuF65-DdVwsh6mUVLNS1acC1QXPKRKaI4rKTJlup9S4ED-X-DiV604Pe9KAzqSnXdGN9dRhur_57PP8F5RKD0w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3124690935</pqid></control><display><type>article</type><title>Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Epardo, David ; Balderas-Márquez, Jerusa E ; Rodríguez-Arzate, Cynthia A ; Thébault, Stéphanie C ; Carranza, Martha ; Luna, Maricela ; Ávila-Mendoza, José ; Calderón-Vallejo, Denisse ; Quintanar, J Luis ; Arámburo, Carlos ; Martínez-Moreno, Carlos G</creator><creatorcontrib>Epardo, David ; Balderas-Márquez, Jerusa E ; Rodríguez-Arzate, Cynthia A ; Thébault, Stéphanie C ; Carranza, Martha ; Luna, Maricela ; Ávila-Mendoza, José ; Calderón-Vallejo, Denisse ; Quintanar, J Luis ; Arámburo, Carlos ; Martínez-Moreno, Carlos G</creatorcontrib><description>Growth hormone (GH) has neuroprotective effects that have not been evaluated in the mammalian visual system. This study tested the hypothesis that GH administration can promote retinal neuroprotection in an optic nerve crush (ONC) model in male rats.
The ON was compressed for 10 seconds, and bovine GH was injected concomitantly to injury for 14 days (0.5 µg/g every 12 hours). At 24 hours and 14 days after ONC, we evaluated the effects of GH upon several markers by quantitative PCR (qPCR), Western blot, and immunohistochemistry; the ON integrity was assessed using CTB Alexa 488 anterograde tracer, and retinal function was tested by full-field electroretinogram.
GH partially prevented the ONC-induced death of retinal ganglion cells (RGCs), as well as the increase in gliosis marker GFAP at 14 days. Most of the ONC-induced changes in mRNA retinal levels of several neurotrophic, survival, synaptogenic, gliosis, and excitotoxicity markers were prevented by GH, both at 24 hours and 14 days, and treatment also stimulated the expression of antiapoptotic proteins Bcl-2 and Bcl-xL at 24 hours. Additionally, GH partially maintained the ON integrity and active anterograde transport, as well as retinal function by avoiding the reduced amplitude and slowing of the A- and B-waves and oscillatory potentials associated with the ONC at 14 days.
GH has neuroprotective effects in the ONC model in male rats, it promoted RGC survival, gliosis reduction, and axonal transport increase, likely through the regulation of genes involved in neuroprotection, survival, and synaptogenesis. Furthermore, GH prevented functional impairment, indicating its potential as a therapeutic option for retinal neurodegenerative diseases.</description><identifier>ISSN: 1552-5783</identifier><identifier>ISSN: 0146-0404</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.65.13.17</identifier><identifier>PMID: 39504048</identifier><language>eng</language><publisher>United States: The Association for Research in Vision and Ophthalmology</publisher><subject>Animals ; Blotting, Western ; Disease Models, Animal ; Electroretinography ; Growth Hormone - pharmacology ; Immunohistochemistry ; Male ; Nerve Crush ; Neuroprotective Agents - pharmacology ; Neuroprotective Agents - therapeutic use ; Optic Nerve Injuries - drug therapy ; Optic Nerve Injuries - metabolism ; Optic Nerve Injuries - pathology ; Rats ; Rats, Sprague-Dawley ; Real-Time Polymerase Chain Reaction ; Retinal Cell Biology ; Retinal Ganglion Cells - drug effects ; Retinal Ganglion Cells - metabolism ; Retinal Ganglion Cells - pathology</subject><ispartof>Investigative ophthalmology & visual science, 2024-11, Vol.65 (13), p.17</ispartof><rights>Copyright 2024 The Authors 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c235t-a94f52d4258e99a87c409919c9fc5739a2c62e9c9382110ca2906457a84e29863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549927/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549927/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39504048$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Epardo, David</creatorcontrib><creatorcontrib>Balderas-Márquez, Jerusa E</creatorcontrib><creatorcontrib>Rodríguez-Arzate, Cynthia A</creatorcontrib><creatorcontrib>Thébault, Stéphanie C</creatorcontrib><creatorcontrib>Carranza, Martha</creatorcontrib><creatorcontrib>Luna, Maricela</creatorcontrib><creatorcontrib>Ávila-Mendoza, José</creatorcontrib><creatorcontrib>Calderón-Vallejo, Denisse</creatorcontrib><creatorcontrib>Quintanar, J Luis</creatorcontrib><creatorcontrib>Arámburo, Carlos</creatorcontrib><creatorcontrib>Martínez-Moreno, Carlos G</creatorcontrib><title>Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat</title><title>Investigative ophthalmology & visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>Growth hormone (GH) has neuroprotective effects that have not been evaluated in the mammalian visual system. This study tested the hypothesis that GH administration can promote retinal neuroprotection in an optic nerve crush (ONC) model in male rats.
The ON was compressed for 10 seconds, and bovine GH was injected concomitantly to injury for 14 days (0.5 µg/g every 12 hours). At 24 hours and 14 days after ONC, we evaluated the effects of GH upon several markers by quantitative PCR (qPCR), Western blot, and immunohistochemistry; the ON integrity was assessed using CTB Alexa 488 anterograde tracer, and retinal function was tested by full-field electroretinogram.
GH partially prevented the ONC-induced death of retinal ganglion cells (RGCs), as well as the increase in gliosis marker GFAP at 14 days. Most of the ONC-induced changes in mRNA retinal levels of several neurotrophic, survival, synaptogenic, gliosis, and excitotoxicity markers were prevented by GH, both at 24 hours and 14 days, and treatment also stimulated the expression of antiapoptotic proteins Bcl-2 and Bcl-xL at 24 hours. Additionally, GH partially maintained the ON integrity and active anterograde transport, as well as retinal function by avoiding the reduced amplitude and slowing of the A- and B-waves and oscillatory potentials associated with the ONC at 14 days.
GH has neuroprotective effects in the ONC model in male rats, it promoted RGC survival, gliosis reduction, and axonal transport increase, likely through the regulation of genes involved in neuroprotection, survival, and synaptogenesis. Furthermore, GH prevented functional impairment, indicating its potential as a therapeutic option for retinal neurodegenerative diseases.</description><subject>Animals</subject><subject>Blotting, Western</subject><subject>Disease Models, Animal</subject><subject>Electroretinography</subject><subject>Growth Hormone - pharmacology</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Nerve Crush</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Optic Nerve Injuries - drug therapy</subject><subject>Optic Nerve Injuries - metabolism</subject><subject>Optic Nerve Injuries - pathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Retinal Cell Biology</subject><subject>Retinal Ganglion Cells - drug effects</subject><subject>Retinal Ganglion Cells - metabolism</subject><subject>Retinal Ganglion Cells - pathology</subject><issn>1552-5783</issn><issn>0146-0404</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1PAjEUbIxGED16NT162bWfu9uTIQTBRCUaPTe1vJU1yxbbLsZ_7xKQ4OnNy0zmTd4gdElJSmmW31RuHdJMppSnND9CfSolS2Re8OMD3ENnIXwSwihl5BT1uJJEEFH00fPEu--4wFPnl64B_AStdyvvIthYrQGPy7JDAQ_LCB6bBs9WsbKdzHfkyLdhgasGxwXgR1MDfjHxHJ2Upg5wsZsD9HY3fh1Nk4fZ5H40fEgs4zImRolSsrlgsgClTJFbQZSiyqrSypwrw2zGoFt50aUm1jBFMiFzUwhgqsj4AN1ufVft-xLmFproTa1Xvloa_6OdqfR_pqkW-sOtNaVSKMXyzuF65-DdVwsh6mUVLNS1acC1QXPKRKaI4rKTJlup9S4ED-X-DiV604Pe9KAzqSnXdGN9dRhur_57PP8F5RKD0w</recordid><startdate>20241106</startdate><enddate>20241106</enddate><creator>Epardo, David</creator><creator>Balderas-Márquez, Jerusa E</creator><creator>Rodríguez-Arzate, Cynthia A</creator><creator>Thébault, Stéphanie C</creator><creator>Carranza, Martha</creator><creator>Luna, Maricela</creator><creator>Ávila-Mendoza, José</creator><creator>Calderón-Vallejo, Denisse</creator><creator>Quintanar, J Luis</creator><creator>Arámburo, Carlos</creator><creator>Martínez-Moreno, Carlos G</creator><general>The Association for Research in Vision and Ophthalmology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20241106</creationdate><title>Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat</title><author>Epardo, David ; Balderas-Márquez, Jerusa E ; Rodríguez-Arzate, Cynthia A ; Thébault, Stéphanie C ; Carranza, Martha ; Luna, Maricela ; Ávila-Mendoza, José ; Calderón-Vallejo, Denisse ; Quintanar, J Luis ; Arámburo, Carlos ; Martínez-Moreno, Carlos G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c235t-a94f52d4258e99a87c409919c9fc5739a2c62e9c9382110ca2906457a84e29863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Blotting, Western</topic><topic>Disease Models, Animal</topic><topic>Electroretinography</topic><topic>Growth Hormone - pharmacology</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Nerve Crush</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Optic Nerve Injuries - drug therapy</topic><topic>Optic Nerve Injuries - metabolism</topic><topic>Optic Nerve Injuries - pathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Retinal Cell Biology</topic><topic>Retinal Ganglion Cells - drug effects</topic><topic>Retinal Ganglion Cells - metabolism</topic><topic>Retinal Ganglion Cells - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Epardo, David</creatorcontrib><creatorcontrib>Balderas-Márquez, Jerusa E</creatorcontrib><creatorcontrib>Rodríguez-Arzate, Cynthia A</creatorcontrib><creatorcontrib>Thébault, Stéphanie C</creatorcontrib><creatorcontrib>Carranza, Martha</creatorcontrib><creatorcontrib>Luna, Maricela</creatorcontrib><creatorcontrib>Ávila-Mendoza, José</creatorcontrib><creatorcontrib>Calderón-Vallejo, Denisse</creatorcontrib><creatorcontrib>Quintanar, J Luis</creatorcontrib><creatorcontrib>Arámburo, Carlos</creatorcontrib><creatorcontrib>Martínez-Moreno, Carlos G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Investigative ophthalmology & visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Epardo, David</au><au>Balderas-Márquez, Jerusa E</au><au>Rodríguez-Arzate, Cynthia A</au><au>Thébault, Stéphanie C</au><au>Carranza, Martha</au><au>Luna, Maricela</au><au>Ávila-Mendoza, José</au><au>Calderón-Vallejo, Denisse</au><au>Quintanar, J Luis</au><au>Arámburo, Carlos</au><au>Martínez-Moreno, Carlos G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat</atitle><jtitle>Investigative ophthalmology & visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2024-11-06</date><risdate>2024</risdate><volume>65</volume><issue>13</issue><spage>17</spage><pages>17-</pages><issn>1552-5783</issn><issn>0146-0404</issn><eissn>1552-5783</eissn><abstract>Growth hormone (GH) has neuroprotective effects that have not been evaluated in the mammalian visual system. This study tested the hypothesis that GH administration can promote retinal neuroprotection in an optic nerve crush (ONC) model in male rats.
The ON was compressed for 10 seconds, and bovine GH was injected concomitantly to injury for 14 days (0.5 µg/g every 12 hours). At 24 hours and 14 days after ONC, we evaluated the effects of GH upon several markers by quantitative PCR (qPCR), Western blot, and immunohistochemistry; the ON integrity was assessed using CTB Alexa 488 anterograde tracer, and retinal function was tested by full-field electroretinogram.
GH partially prevented the ONC-induced death of retinal ganglion cells (RGCs), as well as the increase in gliosis marker GFAP at 14 days. Most of the ONC-induced changes in mRNA retinal levels of several neurotrophic, survival, synaptogenic, gliosis, and excitotoxicity markers were prevented by GH, both at 24 hours and 14 days, and treatment also stimulated the expression of antiapoptotic proteins Bcl-2 and Bcl-xL at 24 hours. Additionally, GH partially maintained the ON integrity and active anterograde transport, as well as retinal function by avoiding the reduced amplitude and slowing of the A- and B-waves and oscillatory potentials associated with the ONC at 14 days.
GH has neuroprotective effects in the ONC model in male rats, it promoted RGC survival, gliosis reduction, and axonal transport increase, likely through the regulation of genes involved in neuroprotection, survival, and synaptogenesis. Furthermore, GH prevented functional impairment, indicating its potential as a therapeutic option for retinal neurodegenerative diseases.</abstract><cop>United States</cop><pub>The Association for Research in Vision and Ophthalmology</pub><pmid>39504048</pmid><doi>10.1167/iovs.65.13.17</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-5783 |
ispartof | Investigative ophthalmology & visual science, 2024-11, Vol.65 (13), p.17 |
issn | 1552-5783 0146-0404 1552-5783 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11549927 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Animals Blotting, Western Disease Models, Animal Electroretinography Growth Hormone - pharmacology Immunohistochemistry Male Nerve Crush Neuroprotective Agents - pharmacology Neuroprotective Agents - therapeutic use Optic Nerve Injuries - drug therapy Optic Nerve Injuries - metabolism Optic Nerve Injuries - pathology Rats Rats, Sprague-Dawley Real-Time Polymerase Chain Reaction Retinal Cell Biology Retinal Ganglion Cells - drug effects Retinal Ganglion Cells - metabolism Retinal Ganglion Cells - pathology |
title | Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A45%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growth%20Hormone%20Neuroprotective%20Effects%20After%20an%20Optic%20Nerve%20Crush%20in%20the%20Male%20Rat&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Epardo,%20David&rft.date=2024-11-06&rft.volume=65&rft.issue=13&rft.spage=17&rft.pages=17-&rft.issn=1552-5783&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.65.13.17&rft_dat=%3Cproquest_pubme%3E3124690935%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3124690935&rft_id=info:pmid/39504048&rfr_iscdi=true |